Viatris Inc. (VTRS)
USD 7.36
(-3.29%)
USD 7.36
(-3.29%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.46 Billion USD | -1.41% |
| 2022 | 3.51 Billion USD | -11.52% |
| 2021 | 3.97 Billion USD | -27.31% |
| 2020 | 5.47 Billion USD | 104.87% |
| 2019 | 2.67 Billion USD | 3.52% |
| 2018 | 2.58 Billion USD | 1.47% |
| 2017 | 2.54 Billion USD | 3.51% |
| 2016 | 2.45 Billion USD | 25.9% |
| 2015 | 1.95 Billion USD | 18.14% |
| 2014 | 1.65 Billion USD | -0.33% |
| 2013 | 1.65 Billion USD | 8.63% |
| 2012 | 1.52 Billion USD | 9.2% |
| 2011 | 1.39 Billion USD | 12.62% |
| 2010 | 1.24 Billion USD | 11.31% |
| 2009 | 1.11 Billion USD | 4.52% |
| 2008 | 1.06 Billion USD | 0.2% |
| 2007 | 1.06 Billion USD | 0.0% |
| 2006 | 279 Million USD | -2.54% |
| 2005 | 279 Million USD | -2.54% |
| 2004 | 286.26 Million USD | -10.76% |
| 2003 | 320.79 Million USD | 0.0% |
| 2002 | 195.07 Million USD | 20.56% |
| 2001 | 161.81 Million USD | 10.93% |
| 2000 | 145.86 Million USD | 6.86% |
| 1999 | 136.5 Million USD | -6.51% |
| 1998 | 146 Million USD | 44.7% |
| 1997 | 100.9 Million USD | 0.3% |
| 1996 | 100.6 Million USD | 28.64% |
| 1995 | 78.2 Million USD | 34.83% |
| 1994 | 58 Million USD | 26.36% |
| 1993 | 45.9 Million USD | 30.77% |
| 1992 | 35.1 Million USD | 20.62% |
| 1991 | 29.1 Million USD | 25.43% |
| 1990 | 23.2 Million USD | 1.31% |
| 1989 | 22.9 Million USD | 14.5% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.94 Billion USD | 3.11% |
| 2024 Q1 | 3.82 Billion USD | 10.19% |
| 2023 FY | 3.46 Billion USD | -1.41% |
| 2023 Q4 | 3.46 Billion USD | -5.51% |
| 2023 Q3 | 3.67 Billion USD | 0.83% |
| 2023 Q1 | 3.66 Billion USD | 4.11% |
| 2023 Q2 | 3.64 Billion USD | -0.62% |
| 2022 Q4 | 3.51 Billion USD | 4.11% |
| 2022 FY | 3.51 Billion USD | -11.52% |
| 2022 Q1 | 3.79 Billion USD | -4.54% |
| 2022 Q2 | 3.61 Billion USD | -4.87% |
| 2022 Q3 | 3.38 Billion USD | -6.42% |
| 2021 Q2 | 4.48 Billion USD | -9.2% |
| 2021 Q3 | 4.08 Billion USD | -9.04% |
| 2021 Q4 | 3.97 Billion USD | -2.55% |
| 2021 FY | 3.97 Billion USD | -27.31% |
| 2021 Q1 | 4.94 Billion USD | -9.68% |
| 2020 Q1 | 2.63 Billion USD | -1.17% |
| 2020 Q2 | 2.78 Billion USD | 5.53% |
| 2020 Q3 | 3.02 Billion USD | 8.48% |
| 2020 Q4 | 5.47 Billion USD | 81.07% |
| 2020 FY | 5.47 Billion USD | 104.87% |
| 2019 Q3 | 2.76 Billion USD | -0.46% |
| 2019 Q4 | 2.67 Billion USD | -3.35% |
| 2019 Q1 | 2.7 Billion USD | 4.98% |
| 2019 FY | 2.67 Billion USD | 3.52% |
| 2019 Q2 | 2.77 Billion USD | 2.49% |
| 2018 Q2 | 2.56 Billion USD | -3.03% |
| 2018 FY | 2.58 Billion USD | 1.47% |
| 2018 Q4 | 2.58 Billion USD | 0.77% |
| 2018 Q3 | 2.56 Billion USD | -0.02% |
| 2018 Q1 | 2.64 Billion USD | 3.87% |
| 2017 Q3 | 2.54 Billion USD | -2.38% |
| 2017 FY | 2.54 Billion USD | 3.51% |
| 2017 Q4 | 2.54 Billion USD | -0.21% |
| 2017 Q2 | 2.61 Billion USD | 2.45% |
| 2017 Q1 | 2.54 Billion USD | 3.72% |
| 2016 Q4 | 2.45 Billion USD | -8.6% |
| 2016 Q2 | 2.19 Billion USD | 2.2% |
| 2016 Q3 | 2.68 Billion USD | 22.64% |
| 2016 FY | 2.45 Billion USD | 25.9% |
| 2016 Q1 | 2.14 Billion USD | 9.9% |
| 2015 Q3 | 1.94 Billion USD | 0.51% |
| 2015 Q1 | 1.9 Billion USD | 15.56% |
| 2015 Q2 | 1.93 Billion USD | 1.36% |
| 2015 Q4 | 1.95 Billion USD | 0.35% |
| 2015 FY | 1.95 Billion USD | 18.14% |
| 2014 Q2 | 1.79 Billion USD | 3.06% |
| 2014 Q4 | 1.65 Billion USD | -3.29% |
| 2014 Q1 | 1.73 Billion USD | 4.89% |
| 2014 Q3 | 1.7 Billion USD | -4.67% |
| 2014 FY | 1.65 Billion USD | -0.8% |
| 2013 FY | 1.66 Billion USD | 9.14% |
| 2013 Q1 | 1.62 Billion USD | 6.43% |
| 2013 Q2 | 1.63 Billion USD | 0.87% |
| 2013 Q4 | 1.65 Billion USD | 0.67% |
| 2013 Q3 | 1.64 Billion USD | 0.0% |
| 2012 FY | 1.52 Billion USD | 9.2% |
| 2012 Q2 | 1.47 Billion USD | -1.0% |
| 2012 Q1 | 1.48 Billion USD | 6.55% |
| 2012 Q3 | 1.49 Billion USD | 1.53% |
| 2012 Q4 | 1.52 Billion USD | 1.96% |
| 2011 Q3 | 1.38 Billion USD | -1.59% |
| 2011 Q1 | 1.32 Billion USD | 6.97% |
| 2011 FY | 1.39 Billion USD | 12.62% |
| 2011 Q4 | 1.39 Billion USD | 0.74% |
| 2011 Q2 | 1.4 Billion USD | 6.2% |
| 2010 Q4 | 1.24 Billion USD | 1.51% |
| 2010 FY | 1.24 Billion USD | 11.31% |
| 2010 Q3 | 1.22 Billion USD | 11.44% |
| 2010 Q2 | 1.09 Billion USD | -5.36% |
| 2010 Q1 | 1.15 Billion USD | 3.97% |
| 2009 Q2 | 1.07 Billion USD | 5.74% |
| 2009 Q1 | 1.01 Billion USD | -4.45% |
| 2009 FY | 1.11 Billion USD | 4.52% |
| 2009 Q4 | 1.11 Billion USD | -0.43% |
| 2009 Q3 | 1.11 Billion USD | 3.9% |
| 2008 Q4 | 1.06 Billion USD | -4.82% |
| 2008 Q2 | 1.15 Billion USD | 1.5% |
| 2008 Q1 | 1.13 Billion USD | 0.0% |
| 2008 FY | 1.06 Billion USD | 0.2% |
| 2008 Q3 | 1.11 Billion USD | -2.66% |
| 2007 Q2 | 432.34 Million USD | 0.75% |
| 2007 FY | 1.06 Billion USD | 281.29% |
| 2007 Q1 | 429.11 Million USD | 36.25% |
| 2007 Q3 | 430.53 Million USD | -0.42% |
| 2006 Q1 | 279 Million USD | 9.97% |
| 2006 Q2 | 289.75 Million USD | 3.85% |
| 2006 Q3 | 303.26 Million USD | 4.66% |
| 2006 Q4 | 314.93 Million USD | 3.85% |
| 2006 FY | 279 Million USD | -2.54% |
| 2005 Q1 | 286.26 Million USD | -2.09% |
| 2005 FY | 286.26 Million USD | -10.76% |
| 2005 Q2 | 261.12 Million USD | -8.78% |
| 2005 Q3 | 255.41 Million USD | -2.19% |
| 2005 Q4 | 253.72 Million USD | -0.66% |
| 2004 Q1 | 320.79 Million USD | 2.95% |
| 2004 Q4 | 292.38 Million USD | -1.42% |
| 2004 Q3 | 296.6 Million USD | -6.01% |
| 2004 FY | 320.79 Million USD | 34.92% |
| 2004 Q2 | 315.57 Million USD | -1.63% |
| 2003 Q4 | 311.6 Million USD | 7.18% |
| 2003 Q2 | 258.16 Million USD | 8.57% |
| 2003 Q1 | 237.77 Million USD | 10.81% |
| 2003 FY | 237.77 Million USD | 21.89% |
| 2003 Q3 | 290.74 Million USD | 12.62% |
| 2002 Q4 | 214.57 Million USD | 9.34% |
| 2002 Q3 | 196.25 Million USD | -5.48% |
| 2002 Q2 | 207.63 Million USD | 6.44% |
| 2002 FY | 195.07 Million USD | 20.56% |
| 2002 Q1 | 195.07 Million USD | -0.87% |
| 2001 Q2 | 170.98 Million USD | 5.67% |
| 2001 FY | 161.81 Million USD | 10.93% |
| 2001 Q4 | 196.77 Million USD | 7.9% |
| 2001 Q3 | 182.37 Million USD | 6.66% |
| 2001 Q1 | 161.81 Million USD | -9.13% |
| 2000 Q1 | 145.86 Million USD | 4.04% |
| 2000 Q3 | 198.39 Million USD | -4.77% |
| 2000 FY | 145.86 Million USD | 6.86% |
| 2000 Q4 | 178.06 Million USD | -10.24% |
| 2000 Q2 | 208.32 Million USD | 42.82% |
| 1999 Q1 | 136.5 Million USD | -7.14% |
| 1999 Q2 | 138.3 Million USD | 1.32% |
| 1999 Q3 | 139.8 Million USD | 1.08% |
| 1999 FY | 136.5 Million USD | -6.51% |
| 1999 Q4 | 140.2 Million USD | 0.29% |
| 1998 Q2 | 150 Million USD | 2.74% |
| 1998 Q1 | 146 Million USD | 7.67% |
| 1998 Q3 | 151 Million USD | 0.67% |
| 1998 Q4 | 147 Million USD | -2.65% |
| 1998 FY | 146 Million USD | 44.7% |
| 1997 Q3 | 132.5 Million USD | 9.23% |
| 1997 Q4 | 135.6 Million USD | 2.34% |
| 1997 Q1 | 100.9 Million USD | 3.7% |
| 1997 FY | 100.9 Million USD | 0.3% |
| 1997 Q2 | 121.3 Million USD | 20.22% |
| 1996 Q1 | 100.6 Million USD | 20.62% |
| 1996 Q4 | 97.3 Million USD | -3.09% |
| 1996 Q3 | 100.4 Million USD | -2.33% |
| 1996 Q2 | 102.8 Million USD | 2.19% |
| 1996 FY | 100.6 Million USD | 28.64% |
| 1995 FY | 78.2 Million USD | 34.83% |
| 1995 Q2 | 76.6 Million USD | -2.05% |
| 1995 Q1 | 78.2 Million USD | 10.3% |
| 1995 Q4 | 83.4 Million USD | 10.9% |
| 1995 Q3 | 75.2 Million USD | -1.83% |
| 1994 Q3 | 71.6 Million USD | 6.07% |
| 1994 Q1 | 58 Million USD | 6.03% |
| 1994 Q2 | 67.5 Million USD | 16.38% |
| 1994 Q4 | 70.9 Million USD | -0.98% |
| 1994 FY | 58 Million USD | 26.36% |
| 1993 Q1 | 45.9 Million USD | 9.81% |
| 1993 Q3 | 51.8 Million USD | 9.05% |
| 1993 FY | 45.9 Million USD | 30.77% |
| 1993 Q2 | 47.5 Million USD | 3.49% |
| 1993 Q4 | 54.7 Million USD | 5.6% |
| 1992 Q1 | 35.1 Million USD | -1.4% |
| 1992 Q3 | 42 Million USD | 11.11% |
| 1992 Q2 | 37.8 Million USD | 7.69% |
| 1992 Q4 | 41.8 Million USD | -0.48% |
| 1992 FY | 35.1 Million USD | 20.62% |
| 1991 Q4 | 35.6 Million USD | 3.49% |
| 1991 Q3 | 34.4 Million USD | 7.17% |
| 1991 FY | 29.1 Million USD | 25.43% |
| 1991 Q2 | 32.1 Million USD | 10.31% |
| 1991 Q1 | 29.1 Million USD | -0.34% |
| 1990 Q2 | 25.3 Million USD | 9.05% |
| 1990 Q3 | 28.5 Million USD | 12.65% |
| 1990 Q4 | 29.2 Million USD | 2.46% |
| 1990 FY | 23.2 Million USD | 1.31% |
| 1990 Q1 | 23.2 Million USD | 2.65% |
| 1989 Q1 | 22.9 Million USD | 0.0% |
| 1989 Q4 | 22.6 Million USD | 3.2% |
| 1989 Q3 | 21.9 Million USD | -7.59% |
| 1989 Q2 | 23.7 Million USD | 3.49% |
| 1989 FY | 22.9 Million USD | 14.5% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -33896.669% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | -3020.346% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -51158.679% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -3224.964% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -60403.021% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -60403.021% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -185480.487% |
| Alpha Teknova, Inc. | 11.59 Million USD | -29826.686% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -10631.473% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -6410.978% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -5187.323% |
| Cosmos Health Inc. | 4.78 Million USD | -72350.634% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -428386.571% |
| Embecta Corp. | 152.1 Million USD | -2181.197% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -29690.504% |
| Procaps Group, S.A. | 96.83 Million USD | -3483.179% |
| Theratechnologies Inc. | 6.06 Million USD | -57099.143% |
| Harrow Health, Inc. | 10.86 Million USD | -31828.775% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -127509.415% |
| Biofrontera Inc. | 10.9 Million USD | -31708.764% |
| DURECT Corporation | 2.21 Million USD | -156263.227% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -4382.353% |
| Cronos Group Inc. | 30.33 Million USD | -11336.443% |
| OptiNose, Inc. | 8.05 Million USD | -42991.157% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -346969999900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -60782.258% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -12180.82% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -129506.083% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -75175.06% |
| Radius Health, Inc. | 278.64 Million USD | -1145.218% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -103681.751% |
| ProPhase Labs, Inc. | 3.84 Million USD | -90233.247% |
| Phibro Animal Health Corporation | 265.91 Million USD | -1204.835% |
| Procaps Group S.A. | 96.83 Million USD | -3483.179% |
| Alvotech | 74.43 Million USD | -4561.508% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Rockwell Medical, Inc. | 5.87 Million USD | -58998.961% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -27365.368% |
| SIGA Technologies, Inc. | 64.21 Million USD | -5302.974% |
| Tilray Brands, Inc. | 252.08 Million USD | -1276.39% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -8578.806% |
| Shineco, Inc. | 1.58 Million USD | -218322.751% |
| PetIQ, Inc. | 159.3 Million USD | -2077.969% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 2271173.06% |
| Incannex Healthcare Limited | -10.01 Million USD | 34745.032% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -8959.269% |
| Alimera Sciences, Inc. | 1.87 Million USD | -184556.732% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -9106.867% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -215356.992% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -77296.832% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1364033.17% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -33326.782% |
| Hempacco Co., Inc. | 2.54 Million USD | -136361.173% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -4561.508% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -7159.698% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -5318.951% |
| Currenc Group, Inc. | 732.91 Thousand USD | -473313.552% |
| Kamada Ltd. | 87.74 Million USD | -3854.221% |
| Indivior PLC | 141.79 Million USD | -2346.906% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -719993.807% |
| Flora Growth Corp. | 8.5 Million USD | -40681.617% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1364033.17% |
| Evolus, Inc. | 10.99 Million USD | -31448.463% |
| HUTCHMED (China) Limited | 50.25 Million USD | -6803.777% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -3178.467% |
| Akanda Corp. | 1.28 Million USD | -269518.166% |